| NOVARTIS NAM. SF 0,50 |
| ISIN | CH0012005267 |
| Security | NOVN |
| Exchange | EUREX |
| Type | Option |
Options
| Exp. date | Type | Type |
|---|---|---|
| 3/20 | 39 Calls | 38 Puts |
| 4/20 | 30 Calls | 30 Puts |
| 6/20 | 24 Calls | 23 Puts |
| 9/20 | 14 Calls | 14 Puts |
| 12/20 | 25 Calls | 25 Puts |
| 6/21 | 13 Calls | 13 Puts |
| 12/21 | 12 Calls | 12 Puts |
| 6/22 | 9 Calls | 9 Puts |
| 12/22 | 9 Calls | 9 Puts |
| 12/23 | 9 Calls | 9 Puts |
| 12/24 | 7 Calls | 7 Puts |
Calls
| Strike | Last | Open Interest | |
|---|---|---|---|
| 120.00 | 2.40 | 80 |
News
- Genmab Board of Directors Chairman to Step Down
02/21/2020 / 21:20 - GlobeNewswire - Novartis Q4 EPS down to $0.5
01/29/2020 / 07:07 - TeleTrader - Novartis nears deal to acquire Medicines - report
11/23/2019 / 20:54 - TeleTrader - Novartis' net sales up 10% to $12.17B in Q3
10/22/2019 / 07:03 - TeleTrader - ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/25/2019 / 17:20 - GlobeNewswire
Real-time